Randomized Phase III Study of UFT+Leucovorin vs. TS-1 as Adjuvant Treatment for Stage III Colon Cancer , and Investigate Predictive Factors Based on Gene Expression
Phase of Trial: Phase III
Latest Information Update: 13 Apr 2018
At a glance
- Drugs Gimeracil/oteracil/tegafur (Primary) ; Folinic acid; Tegafur/uracil
- Indications Colon cancer
- Focus Therapeutic Use
- Acronyms ACTS-CC
- 02 Jun 2015 Results of sub group analysis presented at the 51st Annual Meeting of the American Society of Clinical Oncology.
- 04 Jun 2013 Results presented at the 49th Annual Meeting of the American Society of Clinical Oncology.
- 04 Jun 2013 Primary endpoint 'Disease-free-survival-rate' has been met.